MS-275, a benzamide histone deacetylase inhibitor, prevents osteoclastogenesis by down-regulating c-Fos expression and suppresses bone loss in mice

2012 ◽  
Vol 691 (1-3) ◽  
pp. 69-76 ◽  
Author(s):  
Ha-Neui Kim ◽  
Jong-Ho Lee ◽  
Won Jong Jin ◽  
Sungjin Ko ◽  
Kyoungsuk Jung ◽  
...  
Keyword(s):  
Bone Loss ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Deacetylase Inhibitor ◽  
Fos Expression

scholarly journals The Histone Deacetylase Inhibitor, Vorinostat, Reduces Tumor Growth at the Metastatic Bone Site and Associated Osteolysis, but Promotes Normal Bone Loss

2010 ◽  
Vol 9 (12) ◽  
pp. 3210-3220 ◽  
Author(s):  
Jitesh Pratap ◽  
Jacqueline Akech ◽  
John J. Wixted ◽  
Gabriela Szabo ◽  
Sadiq Hussain ◽  
...  
Keyword(s):  
Bone Loss ◽  
Tumor Growth ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Normal Bone ◽  
Deacetylase Inhibitor
Sign in / Sign up

Export Citation Format

Share Document